Orapred

Advanz Pharma (US) Corp.🇺🇸 United States

FDA Page

Effective Date: Jun 3, 2025
Approval ID: 1e379543-c4cf-4e72-953b-db15b7f0c2a1
Products: 3 registered
Version: 8

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use ORAPRED ODT safely and effectively. See full prescribing information for ORAPRED ODT. ORAPRED ODT (prednisolone sodium phosphate orally disintegrating tablets) Initial U.S. Approval: 1955

Quick Stats

Total Products3

Labelers3

Label Sections34

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.